Cadila Pharmaceuticals

Our branded generic business addresses diverse therapeutic needs throughout the patient’s journey. Cadila Pharma offer solutions across both acute and chronic therapies. A significant share of our branded generics portfolio is manufactured at our own state-of-the-art USFDA-approved facilities, ensuring consistency, safety, and regulatory compliance. Our in-house manufacturing strengthens our supply reliability and reinforces our commitment to a quality-driven healthcare system.

As a multi-therapy branded generics division with selective consumer healthcare extensions, we support a wide spectrum of healthcare needs across:

Gastro-intestinal care

Our gastroenterology therapies are designed to restore digestive balance, relieve discomfort, and support sustained gut health across everyday and complex conditions.

Oncology

Built to extend life and ease suffering, our oncology therapies provide high-quality, affordable care for all patients.

Cardiology

Our cardiology portfolio supports the prevention and management of hypertension and other cardiovascular conditions, helping clinicians deliver consistent, evidence-based care where outcomes matter most.

Diabetology

Driven by care and innovation, we deliver accessible diabetes care solutions that help patients across all geographies and ages.

Neurology

Our neurology portfolio is built around improving quality of life, offering dependable, patient-centric therapies for long-term neurological care.

Gynaecology

Promoting women’s health with our nutritional, fertility, reproductive and pregnancy care.

Orthopaedic

Offering innovative solutions for complex orthopaedic problems, ensuring serenity and relief for ailing patients.

Skincare

The skincare solutions address fungal infections and chronic skin concerns with therapies focused on effective treatment, maintenance, and long-term skin health.

Respiratory

Offering a high-quality product portfolio developed through research to address respiratory needs from chronic management to acute infections.

Vaccines

Delivering key vaccine innovations to boost protection, simplify regimens, and improve patient compliance in high-burden regions.

Anti-Infectives

We develop anti-infective therapies with a clear focus on effectiveness, responsible use, and long-term protection against resistance, supporting safer outcomes worldwide.

Paediatric

A pediatric portfolio targeting common childhood issues, offering safe, effective, child-friendly treatments.

Critical Care

Dedicated to serving critically ill patients with a broad portfolio of high-quality, evidence-based medicines across various therapeutic segments.

Consumer Healthcare (OTC Range)

Our Skinshine OTC range presence paved the way for the broader OTC portfolio, which includes consumer-facing products such as:
Skinshine Day Cream, Face Wash Range, Soap Range, Calamine Lotion, Aloe Vera Gel, Moisturising Lotion, Sun Screen Lotion (SPF 30 and SPF 50), and other cosmetic-care essentials.

Skinshine (15g and 30g)

Skinshine became widely recognised in addressing uneven skin tone and dark patches. Initially available in a 15g pack and later expanded to 30g to meet growing demand, the brand achieved broad acceptance across markets through consistent availability and user familiarity. This established presence paved the way for the broader Skinshine OTC range.

We have a dedicated division focused on delivering comprehensive healthcare solutions across hospitals and government healthcare institutions in India. With a strong focus on quality, access, and trust, the vertical plays a critical role in strengthening Cadila Pharma’s presence in the hospital and institutional segment.

downWhiteCurveArrow

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved